INDRAMEDCO360.50

Indraprastha Medical Corporation Limited

· Pharma & Health
₹ CrorePeersARTEMISMEDSHALBYGKSLGPTHEALTHLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹3,305 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)12.6511.0711.1911.19
Receivable Days (DSO)17.1320.3027.6127.61
Payable Days (DPO)234.61194.08182.47177.43
Cash Conversion Cycle (days)-204.83-162.71-143.67-138.63
Working Capital Turnover8.735.376.006.17
Asset Turnover1.721.591.501.50
Cash Conversion (CFO/Net Income)1.610.970.910.91
CFO/EBITDA1.040.640.630.63
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.